Robert G. Shawah - 13 Feb 2023 Form 4 Insider Report for Acurx Pharmaceuticals, Inc. (ACXP)

Role: Chief Financial Officer
Signature: /s/ Kostantinos Skordalos, Power of Attorney For: Robert G. Shawah
Issuer symbol: ACXP
Transactions as of: 13 Feb 2023
Transactions value $: $0
Form type: 4
Filing time: 24 Feb 2023, 15:32:18 UTC
Previous filing: 06 Jul 2021
Next filing: 03 Apr 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ACXP	Stock Option	Award	$0	+75,000		$0	75,000	13 Feb 2023	Common Stock	75,000	$3.41	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On February 13, 2023 (the " Grant Date"), the Reporting Person was granted stock options to purchase 75,000 shares of the Issuer's common stock. These options vest in 36 equal monthly installments commencing on the Grant Date. This transaction is late due to an inadvertent administrative error and not any error of the Reporting Person.